Association between intestinal microflora and obesity.


Journal

Minerva gastroenterology
ISSN: 2724-5365
Titre abrégé: Minerva Gastroenterol (Torino)
Pays: Italy
ID NLM: 101777280

Informations de publication

Date de publication:
21 Mar 2023
Historique:
entrez: 21 3 2023
pubmed: 22 3 2023
medline: 22 3 2023
Statut: aheadofprint

Résumé

Obesity has become one of modern society's most serious health problems. Studies from the last 30 years revealed a direct relationship between imbalanced energy intake and increased healthcare costs related to the treatment or management of obesity. Recent research has highlighted significant effects of gut microbial composition on obesity. We aimed to report the current knowledge on the definition, composition, and functions of intestinal microbiota. We have performed an extensive review of the literature searching for the following key words: metabolism, gut microbiota, dysbiosis, and obesity. There is evidence that an association between intestinal microbiota and obesity exists at any age. There are complex genetic, metabolic, and inflammatory mechanisms involved in the pathogenesis of obesity. Revision of indications for use of probiotics, prebiotics, and antibiotics in obese patients should be considered. Microbial composition of the gut may be an important factor involved in the development of obesity. Changes in the gut microbiota may result in changes in human metabolism and weight loss.

Identifiants

pubmed: 36943206
pii: S2724-5985.23.03379-X
doi: 10.23736/S2724-5985.23.03379-X
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Maryana Savytska (M)

Department of Normal Physiology, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.

Marko Kozyk (M)

Corewell Health, William Beaumont Hospital, Royal Oak, MI, USA.

Kateryna Strubchevska (K)

Corewell Health, William Beaumont Hospital, Royal Oak, MI, USA.

Kateryna Yosypenko (K)

Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.

Tetyana Falalyeyeva (T)

Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.
Medical Laboratory CSD, Kyiv, Ukraine.

Nazarii Kobyliak (N)

Medical Laboratory CSD, Kyiv, Ukraine.
Department of Endocrinology, Bogomolets National Medical University, Kyiv, Ukraine.

Luigi Boccuto (L)

School of Nursing, Clemson University, Clemson, SC, USA.

Rinaldo Pellicano (R)

Unit of Gastroenterology, Molinette Hospital, Città della Salute e della Scienza, Turin, Italy.

Sharmila Fagoonee (S)

National Research Council, Molecular Biotechnology Center, Institute of Biostructure and Bioimaging, Turin, Italy.

Emidio Scarpellini (E)

Department of Translational Research in Gastrointestinal Disorders (T.A.R.G.I.D.), Gasthuisberg University Hospital, KU Leuven, Leuven, Belgium.

Ludovico Abenavoli (L)

Department of Health Sciences, Magna Græcia University of Catanzaro, Catanzaro, Italy - l.abenavoli@unicz.it.

Classifications MeSH